Celebrex Premedication in Teeth With Symptomatic Irreversible Pulpitis

• Status: Unknown status
• Trial end date: 2019-12-01
• Target enrollment: 0
• Participant gender: All

Summary

Assessing the efficacy of Celebrex premedication on pain during and after endodontic treatment in teeth with symptomatic irreversible pulpits

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Cairo University
• Treatments: Celecoxib

Criteria

Inclusion Criteria:

• Medically free patients

• Patients able to understand Visual Analogue Scale and sign the informed conset

Mandibular molar teeth with:

• Preoperative sharp pain

• Vital pulp tissue

• Normal peripaical radiographic appearance or slight widening of the lamina dura

Exclusion Criteria:

• Patients allergic to NSAIDS

• Pregnant females

• Patients having significant systemic disorder

• Patients with psychological disturbances

• Patients with bruxism or clenching

Teeth that have:

• Associated with swelling or fistulous tract

• Acute or chronic periapical abscess

• Greater than grade I mobility

• Periodontitis

• No possible restorability

• previous endodontic treatment